ANALYST INTERVIEW: THE NEW BIOTECHNOLOGY ENVIRONMENT: SUSHANT KUMAR - MEHTA PARTNERS.(MAK912) THE NEW BIOTECHNOLOGY ENVIRONMENT: SUSHANT KUMAR - MEHTA PARTNERS. Reviews the performance of the industry, and examines recent changes that have impacted companies in that sector. Topics discussed include competition, mergers and acquisitions, and the development of customer demand; and a number of companies are identified that are considered well positioned to succeed in the current market. Sector: Biotechnology. Published date 6/7/01. Tickers featured: ABGX, AFFX, AMGN, AVE, BAYZY, BGEN BGen abbr. brigadier general , CALP, CORR CORR Used on the consolidated tape to indicate a correction in a reported transaction : CORR.LAST.GY 50 WAS 51. , CRA See Community Reinvestment Act. , CRGN, DNA DNA: see nucleic acid. DNA or deoxyribonucleic acid One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes. , HGSI, IDPH, IMMU, INCY, ISPH, LEON, LSBC, MDZ, MEDI, MLNM, MYGN, NVS, OGSI, PDLI, PRCS, RIGL, SCIO, SQNM, VRTX. Complete text approximately 3000 words. Document # MAK912. ANALYST INTERVIEWS, The Wall Street Transcript, 67 Wall Street, NY 10005. Voice (212) 952 7433. Fax: (212) 668-9842. E-mail: transcript@twst.com. *** |
|
||||||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion